APREPITANT Side Effects

6751035-5 | Angina Pectoris, Atrial Fibrillation, Dyspnoea, Non-cardiac Chest Pain
on Jul 10, 2009 Male patient from NETHERLANDS , 77 years of age, was diagnosed with prophylaxis of nausea and vomiting, lung neoplasm malignant and was treated with Aprepitant (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, atrial fibrillation (What is atrial fibrillation?), dyspnoea, non-cardiac chest pain. Aprepitant dosage: 125 Mg/1x Po, 80 Mg/1x Po. During the same period patient was treated with ONDANSETRON HCL (50 Ml/1x Iv) (View Ondansetron Hcl Review and Ondansetron Hcl Label ), DEXAMETHASONE (12 Mg/1x Po) (View Dexamethasone Review and Dexamethasone Label ), GEMCITABINE (2300 Mg/daily Iv) (View Gemcitabine Review and Gemcitabine Label ), CISPLATIN (150 Mg/daily Iv) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6735184-3 | Hiccups
Patient was taking Aprepitant (View Usage). Patient had the following side effects: hiccups on May 19, 2010 from UNITED STATES Additional patient health information: Male patient , 42 years of age, was diagnosed with prophylaxis of nausea and vomiting and. Aprepitant dosage: Daily Po.

6260866-X | Faecaloma, Hypophagia
Adverse event was reported on Jun 26, 2009 by a Male patient taking Aprepitant (View Usage) (Dosage: 125 Mg/1x, Po; 80 Mg/1x, Po) was diagnosed with prophylaxis of nausea and vomiting and. Location: GERMANY , 70 years of age, After Aprepitant was administered, patient had the following side effects: faecaloma, hypophagia. During the same period patient was treated with DEXAMETHASONE (12 Mg/1x, Po; 8 Mg/am; Po) (View Dexamethasone Review and Dexamethasone Label ), ONDANSETRON HCL (50 Mt,/1x, Iv) (View Ondansetron Hcl Review and Ondansetron Hcl Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ). Patient was hospitalized.

6168736-2 | Anaphylactic Shock
on Feb 26, 2009 Female patient from UNITED KINGDOM , 56 years of age, weighting 121.3 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aprepitant (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock. Aprepitant dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ).


6115264-6 | Convulsion
on Feb 05, 2009 Male patient from UNITED KINGDOM , 70 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aprepitant (View Usage). Patient had the following side effects: convulsion. Aprepitant dosage: . During the same period patient was treated with PRIMIDONE (View Primidone Review and Primidone Label ). Patient was hospitalized and became disabled.

6085469-1 | Angina Pectoris, Dyspnoea, Non-cardiac Chest Pain
Patient was taking Aprepitant (View Usage). After Aprepitant was administered, patient had the following side effects: angina pectoris, dyspnoea, non-cardiac chest pain on Feb 09, 2009 from NETHERLANDS Additional patient health information: Male patient , 77 years of age, was diagnosed with prophylaxis of nausea and vomiting, lung neoplasm malignant and. Aprepitant dosage: 125 Mg 1x, Po; 80 Mg 1x, Po. During the same period patient was treated with ONDANSETRON (50 Ml, Iv) (View Ondansetron Review and Ondansetron Label ), DEXAMETHASONE (8 Mg Am, Po) (View Dexamethasone Review and Dexamethasone Label ), CISPLATIN (150 Mg, Iv) (View Cisplatin Review and Cisplatin Label ), GEMCITABINE (2300 Mg, Iv) (View Gemcitabine Review and Gemcitabine Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), PANTOZOL (View Pantozol Review and Pantozol Label ). Patient was hospitalized.

6054590-6 | Flushing, Muscle Twitching, Swollen Tongue
Adverse event was reported on Jan 15, 2009 by a Female patient taking Aprepitant (View Usage) (Dosage: ) was diagnosed with prophylaxis of nausea and vomiting and. Location: AUSTRALIA , 66 years of age, Patient experienced the following unwanted or unexpected effects: flushing, muscle twitching, swollen tongue. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), METFORMIN (View Metformin Review and Metformin Label ), EZETIMIBE AND SIMVASTATIN (View Ezetimibe And Simvastatin Review and Ezetimibe And Simvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

6049436-6 | Flushing, Muscle Twitching, Swollen Tongue
on Jan 15, 2009 Female patient from AUSTRALIA , 66 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Aprepitant (View Usage). Patient had the following side effects: flushing, muscle twitching, swollen tongue. Aprepitant dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), METFORMIN (View Metformin Review and Metformin Label ), EZETIMIBE AND SIMVASTATIN (View Ezetimibe And Simvastatin Review and Ezetimibe And Simvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

5975758-0 | Flank Pain
on Oct 27, 2008 Female patient from AUSTRALIA , 43 years of age, weighting 134.5 lb, was diagnosed with prophylaxis of nausea and vomiting, breast neoplasm and was treated with Aprepitant (View Usage). After Aprepitant was administered, patient had the following side effects: flank pain. Aprepitant dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), EPIRUBICIN HYDROCHLORIDE (View Epirubicin Hydrochloride Review and Epirubicin Hydrochloride Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), ONDANSETRON HYDROCHLORIDE (View Ondansetron Hydrochloride Review and Ondansetron Hydrochloride Label ). Patient was hospitalized.

5876744-1 | Flushing, Muscle Twitching, Swollen Tongue
Patient was taking Aprepitant (View Usage). Patient experienced the following unwanted or unexpected effects: flushing, muscle twitching, swollen tongue on Aug 29, 2008 from AUSTRALIA Additional patient health information: Female patient , 66 years of age, was diagnosed with prophylaxis of nausea and vomiting and. Aprepitant dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), METFORMIN (View Metformin Review and Metformin Label ), EZETIMIBE AND SIMVASTATIN (View Ezetimibe And Simvastatin Review and Ezetimibe And Simvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

5846770-7 | Hallucination, Auditory, Logorrhoea
Adverse event was reported on Aug 08, 2008 by a Male patient taking Aprepitant (View Usage) (Dosage: ) was diagnosed with prophylaxis of nausea and vomiting, bladder cancer (What is bladder cancer?) and. Location: FRANCE , 59 years of age, Patient had the following side effects: hallucination, auditory, logorrhoea. During the same period patient was treated with GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), ONDANSETRON HYDROCHLORIDE (View Ondansetron Hydrochloride Review and Ondansetron Hydrochloride Label ). Patient was hospitalized.

5819884-5 | Acute Respiratory Distress Syndrome, Leukopenia, Multi-organ Failure, Sepsis
on Jul 18, 2008 Male patient from SWEDEN , 40 years of age, was diagnosed with liposarcoma and was treated with Aprepitant (View Usage). After Aprepitant was administered, patient had the following side effects: acute respiratory distress syndrome, leukopenia, multi-organ failure, sepsis (What is sepsis?). Aprepitant dosage: . During the same period patient was treated with TRABECTEDIN (View Trabectedin Review and Trabectedin Label ), DOXORUBICIN (View Doxorubicin Review and Doxorubicin Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), OXYCODONE HYDROCHLORIDE (View Oxycodone Hydrochloride Review and Oxycodone Hydrochloride Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE (View Aluminum Hydroxide And Magnesium Trisilicate Review and Aluminum Hydroxide And Magnesium Trisilicate Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

5755401-6 | Atrial Fibrillation
on May 29, 2008 Female patient from UNITED STATES , weighting 158.0 lb, was treated with Aprepitant (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?). Aprepitant dosage: 80 Mg Po Qd. During the same period patient was treated with ONDANSETRON (View Ondansetron Review and Ondansetron Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ). Patient was hospitalized.

5755265-0 | Anoxia, Febrile Infection, Hypotension, Sepsis
Patient was taking Aprepitant (View Usage). Patient had the following side effects: anoxia, febrile infection, hypotension, sepsis (What is sepsis?) on May 29, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 190.9 lb, . Aprepitant dosage: 80 Mg Po Qd. During the same period patient was treated with ONDANSETRON (View Ondansetron Review and Ondansetron Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ). Patient was hospitalized.

5072721-1 | Lymph Node Pain, Lymphadenopathy, Musculoskeletal Pain, Neck Pain, Ocular Hyperaemia, Pyrexia, Urticaria
Adverse event was reported on Jul 19, 2006 by a Female patient taking Aprepitant (View Usage) (Dosage: 125-80-80) was diagnosed with colon cancer stage ii and. Location: GREECE , 52 years of age, After Aprepitant was administered, patient had the following side effects: lymph node pain, lymphadenopathy, musculoskeletal pain, neck pain, ocular hyperaemia, pyrexia, urticaria. During the same period patient was treated with ONDANSETRON HCL (View Ondansetron Hcl Review and Ondansetron Hcl Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), ELOXATIN (View Eloxatin Review and Eloxatin Label ).

5063605-3 | Lymph Node Pain, Lymphadenopathy, Musculoskeletal Pain, Neck Pain, Ocular Hyperaemia, Pyrexia, Urticaria
on Jul 19, 2006 Female patient from GREECE , 52 years of age, was diagnosed with colon cancer stage ii and was treated with Aprepitant (View Usage). Patient experienced the following unwanted or unexpected effects: lymph node pain, lymphadenopathy, musculoskeletal pain, neck pain, ocular hyperaemia, pyrexia, urticaria. Aprepitant dosage: 125-80-80. During the same period patient was treated with ONDANSETRON HCL (View Ondansetron Hcl Review and Ondansetron Hcl Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), ELOXATIN (View Eloxatin Review and Eloxatin Label ).

4884447-5 | Hiccups
on Jan 17, 2006 Male patient from UNITED STATES , 61 years of age, was treated with Aprepitant (View Usage). Patient had the following side effects: hiccups. Aprepitant dosage: .

4884444-X | Hiccups
Patient was taking Aprepitant (View Usage). After Aprepitant was administered, patient had the following side effects: hiccups on Jan 17, 2006 from UNITED STATES Additional patient health information: Male patient , 45 years of age, . Aprepitant dosage: .